Hedgehog (Hh) morphogens have fundamental roles in development, whereas dysregulation of Hh signaling leads to disease. Multiple cell-surface receptors are responsible for transducing and/or regulating Hh signals. Among these, the Hedgehoginteracting protein (Hhip) is a highly conserved, vertebrate-specific inhibitor of Hh signaling. We have solved a series of crystal structures for the human HHIP ectodomain and Desert hedgehog (DHH) in isolation, as well as HHIP in complex with DHH (HHIP-DHH) and Sonic hedgehog (Shh) (HHIP-Shh), with and without Ca 2+ . The interaction determinants, confirmed by biophysical studies and mutagenesis, reveal previously uncharacterized and distinct functions for the Hh Zn 2+ and Ca 2+ binding sites-functions that may be common to all vertebrate Hh proteins. Zn 2+ makes a key contribution to the Hh-HHIP interface, whereas Ca 2+ is likely to prevent electrostatic repulsion between the two proteins, suggesting an important modulatory role. This interplay of several metal binding sites suggests a tuneable mechanism for regulation of Hh signaling.
A handful of secreted growth factors and morphogens are responsible for almost all developmental decisions during embryogenesis and among these, Hh family proteins are ubiquitous players in tissue growth, patterning and morphogenesis 1, 2 . Dysregulation of Hh signaling has pathological consequences, triggering developmental defects 3 , neurodegenerative diseases 4 and cancer 5 .
The Hh signaling pathway is broadly conserved in vertebrates and invertebrates, but the number of Hh ligands has expanded during evolution (one Hh in Drosphila spp. and three in mammals: Shh, Dhh and Indian hedgehog (Ihh)) 1 . Mature Hh proteins are derived from Hh protein precursors by autoprocessing and lipid attachment to generate a dually lipid-modified N-terminal signaling domain (HhN) 6 . These modifications facilitate the integration of Hh into multimeric lipoprotein particles 7, 8 . Hh constructs lacking the lipid attachment sites have the same receptor binding properties, but their tissue distribution is impaired 6,9 . The extracellular regulation of signaling is more complex in vertebrates than in invertebrates. Transduction of Hh signals into cells is mediated by the two transmembrane receptors Smoothened (Smo) and Patched (Ptc1) 10 . The Interference hedgehog protein family (Ihog in the fruitfly and CDON and BOC in humans) 11 and heparan sulfate proteoglycans (HSPGs) 12 act as crucial modulators in both vertebrates and invertebrates, whereas Hhip 13 and growth arrestspecific gene 1 (Gas1) 14 are vertebrate-specific.
Hhip is an inhibitor of Hh signaling. It is attached to the cell surface by a C-terminal helix and binds all three Hh ligands (Shh, Ihh and Dhh) with nanomolar affinity 13 . Cells exposed to Hh upregulate both Ptc1 and Hhip expression 13 . A secreted version of Hhip can also sequester Hh, thus interfering with Hh signaling 15 . Hhip functions in cartilage development 13 as well as nerve development 16 and axon guidance 17 , and its expression is altered in various cancers [18] [19] [20] [21] . Despite this wealth of data regarding the biological role, the molecular mechanisms underlying Hhip function are still unknown. We therefore undertook an analysis of the structural and binding characteristics of human HHIP-Hh interactions.
RESULTS

Structure of the human HHIP ectodomain
We produced a series of HHIP constructs in mammalian HEK-293T cells 22 (see Online Methods for details). The full-length ectodomain of human HHIP (eHHIP, residues 56-670) fragmented during expression; however, mutation of the proteolytic recognition sequences (Arg189, Arg210 and Lys211 to alanine; eHHIPS construct; Fig. 1a ) or an N-terminal truncation of the first 213 amino acid residues (eHHIPDN construct) resulted in proteolytically stable and homogeneous proteins. The stabilized full-length ectodomain is dimeric, whereas eHHIPDN exists as a monomer ( Supplementary Fig. 1 ), suggesting a function for the N-terminal cysteine-rich domain in mediating dimerization, although we cannot rule out the possibility that dimerization might be a consequence of mutagenesis.
We were unable to crystallize the stabilized ectodomain of HHIP, but eHHIPDN yielded well-ordered crystals. We solved the structure using selenomethionine (SeMet)-labeled protein for phasing ( Fig. 1b) . Refinement resulted in an R-factor of 20.1% (R free : 23.9%) to 2.8-Å resolution, with two eHHIPDN molecules in the crystallographic asymmetric unit ( Supplementary Fig. 2 ). The eHHIPDN monomer is composed of an N-terminal six-bladed b-propeller domain (residues 214-583) linked to two epidermal growth factor (EGF) repeat domains (residues 607-637 and 638-670, respectively) ( Fig. 1c) . The main atypical characteristic of the HHIP b-propeller is a large protrusion of two loops from blade 3, which form an extensive negatively charged patch on the surface (Fig. 1d) . The b-propeller is connected to the EGF repeats by 28 residues. This well-ordered linker ( Fig. 1b ,c, orange) stretches across the b-propeller (over blades 6, 1 and 2). The disulfide bonds ( Fig. 1c ) that stabilize the linker (I, IV and VI) and the orientation of the first EGF repeat (II and VI) are conserved in all known Hhip receptors ( Supplementary Fig. 3 ). This rigid arrangement forms a structural unit; attempts to produce truncated forms of HHIP lacking the first EGF repeat failed (unpublished data). The EGF repeats have a linear, elongated conformation, with the C terminus of the second EGF repeat pointing away from the b-propeller domain. The major difference between the two HHIP molecules in the asymmetric unit is the relative orientation of the second EGF repeat ( Supplementary Fig. 2 ), reflecting the flexibility between the EGF domains. This hinge may provide a necessary degree of freedom in the membrane-proximal region of the ectodomain (which is tethered to the cell surface only 9 residues downstream of the second EGF repeat).
Structure of the HHIP-Shh complex
We next produced ( Supplementary Fig. 4 ) the complex between eHHIPDN and the N-terminal signaling domain of mouse Shh (ShhN, a monomeric construct that lacks the lipid-modification sites) and determined its crystal structure to 3.2-Å resolution. ShhN uses a surface oriented away from its termini (which are lipid modified in vivo) to interact with the two distinctive loops (BL1 and BL2) protruding from blade 3 of the HHIP b-propeller (Figs. 1d and 2a,b). Two disulfide bridges at the beginning and the end of blade 3 (disulfide bridges II and III in Fig. 2a ) stabilize the blade for reception of the Hh ligand, whereas the C-terminal EGF repeats and the membrane-proximal region of HHIP are oriented away from the ligand binding site. The complex interface buries 840 Å 2 of eHHIPDN and 759 Å 2 of ShhN, with a surface-complementarity score (sc) of 0.66. The complex is stabilized by 13 potential hydrogen bonds, 157 nonbonded van der Waals contacts and one Zn 2+ ion, involving a total of 14 residues of the HHIP receptor and 20 residues of ShhN ( Supplementary Figs. 3 and 5a ). Detailed interactions are depicted in Figure 2c -f. In eHHIPDN, BL1 (residues 370-391, harboring a small a-helical segment) forms the main interaction interface, inserting into the Shh Zn 2+ binding cavity ( Fig. 2b,c) . The carboxylate group of HHIP-Asp383, located at the tip of BL1, completes the coordination of the Zn 2+ binding site, which is formed by Shh residues His141, Asp148 and His183 (Fig. 2d) . The presence of Zn 2+ was verified by coordination geometry 23 , X-ray absorption and fluorescence scans and anomalous scattering (Supplementary Fig. 6 ). Two Ca 2+ ions, coordinated by Shh residues Glu90, Glu91, Asp96, Thr126, Glu127 and Asp130 ( Fig. 2f) , are also clearly visible in the electron density maps ( Supplementary Fig. 6d ), and they seem to have an important role in the stabilization of a Shh loop (Lys88-Gly94; discussed below). The second HHIP loop, which also contributes to binding (BL2), interacts with a Shh surface patch adjacent to the Zn 2+ binding cavity, forming three potential hydrogen bonds and several van der Waals contacts ( Fig. 2e ).
Importance of metal binding sites for HHIP-Hh interactions
Although the eHHIPDN-ShhN interface is relatively small and the surface complementarity score is at the lower end of the scale for physiological protein-protein interactions, we observed binding constants in the nanomolar range using surface plasmon resonance (SPR), (Fig. 3a,b and Supplementary Fig. 7 ), in agreement with previously reported cell-based measurements 13 . The HHIP ectodomain (including the N-terminal cysteine-rich dimerization domain; Fig. 1a ) and eHHIPDN showed similar Hh binding behavior, although the full-length form has somewhat enhanced binding, which may reflect its dimeric state ( Fig. 3) . For both HHIP constructs, the presence of Zn 2+ in the Hh metal binding site is crucial ( Fig. 3) . Addition of 10 mM EDTA (a chelator for divalent cations) completely abolished Hh binding ( Fig. 3d) or, in the presence of Ca 2+ , mutation of the Zn 2+ -coordinating HHIP-Asp383 ( Fig. 2c,d ) to arginine or alanine abolished Hh binding or reduced it by more than 25-fold, respectively ( Fig. 3a) . Thus, the tight Hh-HHIP interaction can be explained by the contribution of HHIP to the coordination of Zn 2+ in the Hh ligand metal binding site (Fig. 2d ). The first report of the crystal structure of ShhN 24 identified the Zn 2+ binding site 24 , and pointed out a similarity to the Zn 2+ -containing active sites of some metalloproteases. Zn 2+ seems to have a crucial structural role, binding ShhN with high affinity (K d r 100 pM) 25 . However, the HHIP-ShhN structure reveals a second role: Zn 2+ binding is the key mediator of complex formation; indeed, the Zn 2+ binding site is not conserved in D. melanogaster ( Supplementary Fig. 5a ), which correlates with the absence of Hhip in flies.
The low-affinity (K d Z 100 mM 26 ) Ca 2+ binding site ( Fig. 2f ) adopts a previously described conformation reported to be important for Shh binding to various cell-surface receptors 26 . We confirmed this finding in SPR experiments, where addition of 2 mM Ca 2+ caused a marked increase of the Hh-HHIP binding affinity (K d from 100 nM to 6 nM; Fig. 3a-c and Supplementary Fig. 7 ). However, our structure reveals that neither the two Ca 2+ ions nor the loops coordinating them contribute specific interactions to the complex interface, suggesting a secondary role for the Ca 2+ ions in HHIP binding. We therefore investigated the effect of Ca 2+ absence on the structure of Hh ligands and, subsequently, on Hh-HHIP structures. In the previously published uncomplexed ShhN structure 24 , in the absence of Ca 2+ , the side chains of Glu90, Glu91 are oriented toward the solvent (Fig. 4a ). To verify whether this applies to other Hh ligands, we solved crystal structures of the N-terminal signaling domain of human DHH (DHHN, equivalent to the ShhN construct), with and without bound Ca 2+ . The overall architecture of DHHN, including the Zn 2+ binding site, closely matches that of ShhN (r.m.s. deviation 0.5 Å for 150 Ca atoms; Fig. 4a ), as expected from the high degree of sequence identity (77%; Supplementary Fig. 5 ). The conformations of the Glu90 and Glu91 side chains in the Ca 2+ -free forms of ShhN 24 and DHHN match, whereas for DHHN with Ca 2+ bound, these residues contribute to metal coordination and adopt the conformation observed in the ShhN-eHHIPDN complex ( Fig. 4a and Supplementary Fig. 8 ). We produced, crystallized and solved the structures of ShhN-eHHIPDN and DHHN-eHHIPDN complexes in the absence of Ca 2+ (Supplementary Fig. 4) . The structures show that the Hh residues contributing to the Hh-HHIP interface are highly similar across family members and vertebrate species (Fig. 4b and Supplementary Fig. 5 ), conserving the architecture of the ligand-receptor interfaces ( Fig. 4c and Supplementary Fig. 9 ). In the absence of Ca 2+ , the Hh loop Lys88-Gly94 becomes disordered, suggesting that Ca 2+ binding is important to prevent electrostatic repulsion between the negatively charged residues of Hh loop Lys88-Gly94 and a negatively charged patch (formed by HHIP residues Asp377, Glu380, Glu381, Asp383) on the apposing HHIP surface (Fig. 2f) . In the presence of Ca 2+ , stabilization of the loop allows the side chains of HHIP-Glu381 and Shh-Glu90 to contribute to the complex by forming additional van der Waals interactions (Fig. 4d) , consistent with the observed 20-fold to 60-fold increase in affinity between Hh ligands and HHIP under these conditions (Fig. 3a) .
A previously reported structure of ShhN in complex with the third fibronectin type III domain of CDON showed Ca 2+ to be essential for binding 26 , and the conformation of the Ca 2+ binding site is essentially identical to the ones we observed in the DHHN and ShhN-eHHIPDN structures ( Supplementary Fig. 8) . A comparison of the Shh-HHIP and Shh-CDON complexes shows a partial overlap of the receptor binding interfaces, which includes residues of the Shh loop Lys88-Gly94; however, HHIP and CDON have different orientations relative to the Hh ligand (Fig. 4e) . The Shh-CDON interface does not include direct interactions with the Zn 2+ binding site and is less extensive, in agreement with solution binding assays: K d Shh-CDON ¼ 1,300 nM 26 and K d Shh-HHIP ¼ 6 nM (Fig. 3a) . In our Shh-HHIP and DHH-HHIP complexes, the Zn 2+ binding site is crucial for complex formation and, even in the absence of Ca 2+ , the Hh-HHIP affinities are ten times higher than that reported for the Shh-CDON complex (Fig. 3a) .
DISCUSSION
The structural similarity between the Hh Zn 2+ binding site and the active site of Zn 2+ -hydrolases strongly suggests that these classes of proteins are evolutionarily related. However, alteration of Shh residues, which by analogy should be essential for hydrolytic activity, did not impair signaling via Ptc1, thus ruling out a functional requirement for enzymatic catalysis 27 . The fact that this site is not conserved in any Drosophila species sequenced to date, although it is maintained in all other closely related Hh orthologs from insects and other invertebrates ( Supplementary Fig. 5 ), further suggests that it is not required for the canonical signaling pathways, such as that of Ptc1. Nevertheless, vertebrates may potentially have exploited the presence of this Zn 2+ binding site to diversify the repertoire of Hh-interacting proteins to include the Hhip receptor, thus introducing an additional level of regulation in this signaling pathway.
Mutations of SHH-His140 and SHH-Cys183 (residues directly or indirectly involved in Zn 2+ chelation) cause holoprosencephaly (HPE) and other facial anomalies as well as cancer in humans 28, 29 . The ShhN-CDON interaction seems to be Zn 2+ -independent 26 and, as discussed above, Drosphila Hh lacks the Zn 2+ binding site. Although site-directed mutagenesis of residues forming the Zn 2+ binding site led to a marked decrease of Shh potency in a cellular differentiation assay, it was not clear whether this effect was due solely to a decrease in protein stability 25 . However, as functional activity was not completely abolished, interactions with other vertebrate Hh receptors (for example, Ptc1) may not be entirely dependent on the presence of Zn 2+ . In contrast, Zn 2+ clearly has a central role in Hh ligand binding to Hhip; thus, the Zn 2+ and Ca 2+ binding sites have distinct functions in defining the specificities of Hh interactions with cellsurface receptors.
For the Hh-HHIP interaction, our results reveal a secondary role for the Ca 2+ binding sites. The local concentration of extracellular Ca 2+ is highly variable 30 , so the occupancy of the low-affinity binding site in Hh may vary. The juxtaposition of one metal binding site, which takes the lead role in protein-protein interaction, with additional sites, which modulate the binding affinity, is strongly reminiscent of ligand binding by the integrin family of cell-adhesion molecules. For example, in the structure of the integrin a IIb b 3 -fibrinogen gC peptide, the interface is centered on the integrin metal ion-dependent adhesion site (MIDAS, a high-affinity magnesium binding site) but has direct contributions from the 'adjacent to MIDAS' (ADMIDAS) Ca 2+ binding site 31 . In general, for the integrin system, the MIDAS metal ion has been shown to have a direct role in ligand binding, whereas the ADMIDAS metal ion has a regulatory function. Similarly, our results suggest that the interplay between the Zn 2+ and Ca 2+ binding sites in vertebrate Hh ligands may allow extracellular Ca 2+ concentration to take an important modulatory role. 
METHODS
Methods
ONLINE METHODS
Production of the human hedgehog-interacting protein HHIP ectodomain. We cloned human HHIP ectodomain constructs (GenBank NP_071920; eHHIP, residues 56-670; eHHIPDN, residues 214-670) into the pHLsec vector 22 and expressed these by transient transfection in HEK-293T cells in the presence of kifunensine 32 . Proteins were purified from dialyzed conditioned medium by immobilized metal-affinity chromatography and treated with endoglycosidase F1 (ref. 32) to cleave glycosidic bonds of N-linked sugars. We concentrated the proteins and further purified them by size-exclusion chromatography in 10mM HEPES, pH 7.5, 150 mM NaCl. SeMet-labeled eHHIPDN was produced as described 22 .
Production of ShhN and DHHN, and complex formation with HHIP. We produced the N-terminal signaling domain of mouse Sonic hedgehog (residues 40-194, GenBank NP_033196) as described above, although we did not use kifunensine because ShhN is not glycosylated. Mouse ShhN differs in only one residue to human ShhN (a structurally conserved exchange of Thr68 to serine) and it is likely that the structure of human SHHN is essentially identical to that of the murine ortholog. Human DHHN (residues 39-194, GenBank NP_066382) was cloned into the pET22b expression plasmid (Novagen) and expressed in E. coli Rosetta(DE3)pLysS cells. Cultures were grown at 37 1C to an absorbance at 600 nm (A 600 ) of 0.8, cooled to 20 1C, induced with 0.25 mM IPTG and then grown for B15 h before harvesting. We resuspended the bacterial pellets in 25 mM sodium phosphate, pH 8.0, 500 mM NaCl, 1 mM b-mercaptoethanol and EDTA-free protease inhibitor cocktail (Roche). Cells were broken using a Basic Z model cell disruptor (Constant Systems) and fractionated by centrifugation (30,000g, 5 1C, 30 min). We purified DHHN from the supernatant by immobilized metal-affinity chromatography and size-exclusion chromatography in 10 mM HEPES, pH 7.5, 150 mM NaCl. The ShhN-eHHIPDN and DHHN-eHHIPDN complexes were formed by mixing a molar ratio of 1.5:1 purified Hh ligand to the eHHIPDN receptor and incubating for 1 h at room temperature (20 1C), and we purified the complexes by size-exclusion chromatography in 10 mM HEPES, pH 7.5, 150 mM NaCl, with or without 2 mM CaCl 2 .
Crystallization and data collection. Prior to crystallization, we concentrated the proteins by ultrafiltration (eHHIPDN, 4 mg ml -1 ; eHHIPDN-ShhN, 8 mg ml -1 ; eHHIPDN-DHHN, 10 mg ml -1 ; DHHN, 7 mg ml -1 ). We set-up nanoliter crystallization trials using a Cartesian Technologies robot (100 nl protein solution plus 100 nl reservoir solution) in 96-well Greiner plates 33 Diffraction data were collected at 100 K, crystals being flash-cooled in a cryo N 2 gas stream. Before flash-freezing, we treated crystals with the appropriate cryoprotectant solutions (eHHIPDN: 0.1 M Tris-HCl, 4.5 M potassium formate; eHHIPDN-ShhN: perfluoropolyether oil PFO-X125/03 (Lancaster Synthesis); eHHIPDN-DHHN; DHHN: 25% (v/v) glycerol in mother liquor). Data were collected at beamline ID29 (native and SeMet-labeled eHHIPDN (l ¼ 0.9792), eHHIPDN-ShhN with Ca 2+ (l ¼ 0.9762), eHHIPDN-DHHN (l ¼ 0.9793) and DHHN with Ca 2+ (l ¼ 0.9762)) at the European Synchrotron Radiation Facility, France, and at beamlines I02 (DHHN without Ca 2+ (l ¼ 0.9507)) and I03 (eHHIPDN-ShhN without Ca 2+ (l ¼ 0.8900)) at the Diamond Light Source, UK. X-ray data were processed and scaled with the HKL suite 34 . The program XPREP (http://www.bruker-axs.com/) was used to calculate quality indicators and to merge data. Data collection statistics are shown in Table 1 .
Structure determination and refinement. The eHHIPDN crystal structure was determined by SAD analysis. The positions of 12 selenium atoms were determined by using SHELXD 35 . This solution was input into AUTOSHARP 36 for phase calculation, improvement and phase extension using the highresolution native data to 2.8-Å resolution. The resulting map was of high quality and allowed tracing of the whole polypeptide chain. An initial model was built automatically using RESOLVE 37 and completed by hand using COOT 38 . Noncrystallographic symmetry restraints were used to refine the model using the programs BUSTER 39 , REFMAC 40 and Phenix 41 .
We solved the DHHN structures by molecular replacement using PHASER 42 with the structure of mouse ShhN (PDB 1VHH 24 ) as search model. This solution was input into ARP/WARP 43 for automated model building and manually adjusted and refined using COOT 38 and REFMAC 40 .
We solved the eHHIPDN-ShhN complexes with and without Ca 2+ and the eHHIPDN-DHHN complex by molecular replacement using PHASER with the eHHIPDN structure and the ShhN (PDB 1VHH 24 ), or DHHN structures as search models, respectively. The resulting electron density maps were of high quality and allowed manual adjustment and refinement of the complex structures using COOT 38 , BUSTER 39 , REFMAC 40 and Phenix 41 .
Refinement statistics are given in Table 1 ; all data within the indicated resolution range were included. Stereochemical properties were assessed by MOLPROBITY 44 46 and electrostatic potentials were generated using APBS 47 . SC 48 was used to calculate the surface complementarity scores. Buried surface areas of protein-protein interactions were calculated using the PISA webserver (http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html).
Site-directed mutagenesis. Mutations were generated by a two-step overlapping PCR using Pyrobest Polymerase (Takara). PCR products were cloned into the pHLsec mammalian expression vector, resulting in protein constructs with a C-terminal His 6 tag or with a C-terminal BirA recognition sequence 22 . Mutant proteins were secreted at similar levels to the wild-type eHHIPDN and ShhN (unpublished data). The stringent quality control mechanisms specific to the mammalian cell secretory pathway ensure that secreted proteins are correctly folded 49 .
Multiangle light scattering. MALS experiments were carried out using an analytical Superdex S200 10/30 column (GE Heathcare) with online static lightscattering (DAWN HELEOS II, Wyatt Technology), differential refractive index (Optilab rEX, Wyatt Technology) and Agilent 1200 UV (Agilent Techologies) detectors. Proteins used for MALS were fully glycosylated and had previously been purified by size-exclusion chromatography and concentrated to approximately 2 mg ml -1 . Data were analyzed using the ASTRA software package (Wyatt Technology).
Surface plasmon resonance binding studies. SPR experiments were performed using a Biacore T100 machine (GE Healthcare) at 25 1C in 10 mM HEPES, pH 7.5, 150 mM NaCl, 0.05% (v/v) polysorbate 20, supplemented with 2 mM CaCl where indicated. All proteins were homogeneous with full biological activity and underwent gel filtration in running buffer immediately before use. Protein concentrations were determined from the absorbance at 280 nm using calculated molar extinction coefficients. Proteins for surface attachment were enzymatically biotinylated within an engineered C-terminal tag. The native membrane insertion topology was recapitulated by attachment of 200-2,000 response units (RU) of biotinylated protein to surfaces on which 3,000 RU of streptavidin were coupled via primary amines 50 . Experiments with wild-type proteins were performed in both orientations and with mutant proteins in one orientation. The signal from experimental flow cells was corrected by subtraction of a blank and reference signal from a mock or irrelevant protein coupled flow cell. In all experiments analyzed, the experimental trace returned to baseline after each injection (Fig. 3b-d and Supplementary Fig. 7 ) and the data fitted to a simple 1:1 Langmuir model of binding. K d values were obtained by nonlinear curve fitting of the Langmuir binding isotherm (bound ¼ C*max/ (K d + C), where C is analyte concentration and max is the maximum analyte binding) to the data using the Levenberg-Marquardt algorithm implemented in the program Origin (Microcal Software).
